Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.

In a recent review published in the journal Nature Reviews Immunology, researchers discussed the limitations of current influenza vaccines and the potential for future vaccines to induce both T-cell ...

Influenza prevention with the cell-based quadrivalent vaccine (QIVc) was superior to the egg-based vaccine (QIVe) during the US 2022–2023 flu season.

Americans are being urged to be extra vigilant this winter, as a suite of influenza A mutations has created a dominant virus ...

H5N1 avian influenza is highly pathogenic and has been devastating bird populations worldwide. It continues to do so, and is also moving into new animals, like skunks, bears, raccoons, cats, and dairy ...

St. Jude Children's Research Hospital scientists, in collaboration with the Institute of Environmental Science and Research (ESR) Limited, found that immune cells present in people months before ...

As cases of H5N1 bird flu rise across the U.S., some of us may be more immune to the virus than others. Many people may have immune cells called "T cells" primed and ready to fight the "highly ...

Most influenza viruses enter human or animal cells through specific pathways on the cells’ surface. Researchers at the University of Zurich have now discovered that certain human flu viruses and avian ...

Researchers have discovered some new and surprising ways that viral RNA and influenza virus are detected by human lung cells, which has potential implications for treating people affected by such ...

On the dashboard released Wednesday on the county's website, a summary chart breaks down how a virus is circulating in the ...